FR2043489B1 - - Google Patents

Info

Publication number
FR2043489B1
FR2043489B1 FR696917560A FR6917560A FR2043489B1 FR 2043489 B1 FR2043489 B1 FR 2043489B1 FR 696917560 A FR696917560 A FR 696917560A FR 6917560 A FR6917560 A FR 6917560A FR 2043489 B1 FR2043489 B1 FR 2043489B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696917560A
Other languages
French (fr)
Other versions
FR2043489A1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Organisation de Synthese Mondiale Orsymonde SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organisation de Synthese Mondiale Orsymonde SA filed Critical Organisation de Synthese Mondiale Orsymonde SA
Priority to FR696917560A priority Critical patent/FR2043489B1/fr
Priority to CH741470A priority patent/CH509975A/fr
Priority to BE750619D priority patent/BE750619A/xx
Priority to DE2024693A priority patent/DE2024693C3/de
Priority to NL7007517.A priority patent/NL166473C/xx
Priority to GB25490/70A priority patent/GB1268587A/en
Priority to US00041637A priority patent/US3729470A/en
Priority to JP45045977A priority patent/JPS4941184B1/ja
Publication of FR2043489A1 publication Critical patent/FR2043489A1/fr
Application granted granted Critical
Publication of FR2043489B1 publication Critical patent/FR2043489B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR696917560A 1969-05-29 1969-05-29 Expired FR2043489B1 (en:Method)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR696917560A FR2043489B1 (en:Method) 1969-05-29 1969-05-29
CH741470A CH509975A (fr) 1969-05-29 1970-05-19 Procédé de préparation de dérivés de la phloramine
BE750619D BE750619A (fr) 1969-05-29 1970-05-20 Derives de la phloramine
DE2024693A DE2024693C3 (de) 1969-05-29 1970-05-21 Substituierte Aminoacetanilide und deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
NL7007517.A NL166473C (nl) 1969-05-29 1970-05-25 Werkwijze voor de bereiding van alkylaminoacyl- aniliden, alsmede gedoseerd farmaceutisch preparaat.
GB25490/70A GB1268587A (en) 1969-05-29 1970-05-27 Phloramine derivatives
US00041637A US3729470A (en) 1969-05-29 1970-05-28 Alpha-(3,5-dimethoxy)aminoacetanilides
JP45045977A JPS4941184B1 (en:Method) 1969-05-29 1970-05-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR696917560A FR2043489B1 (en:Method) 1969-05-29 1969-05-29

Publications (2)

Publication Number Publication Date
FR2043489A1 FR2043489A1 (en:Method) 1971-02-19
FR2043489B1 true FR2043489B1 (en:Method) 1973-07-13

Family

ID=9034767

Family Applications (1)

Application Number Title Priority Date Filing Date
FR696917560A Expired FR2043489B1 (en:Method) 1969-05-29 1969-05-29

Country Status (8)

Country Link
US (1) US3729470A (en:Method)
JP (1) JPS4941184B1 (en:Method)
BE (1) BE750619A (en:Method)
CH (1) CH509975A (en:Method)
DE (1) DE2024693C3 (en:Method)
FR (1) FR2043489B1 (en:Method)
GB (1) GB1268587A (en:Method)
NL (1) NL166473C (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931314A (en) * 1972-05-12 1976-01-06 Cassella Farbwerke Mainkur Aktiengesellschaft Benzophenone derivatives and process for their production
DE2346937A1 (de) * 1973-09-18 1975-04-03 Bayer Ag N'-(aminoacylaminophenyl)-acetamidine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4070485A (en) * 1974-03-18 1978-01-24 Science Union Et Cie Alkoxy anilides process for preparing the same and pharmaceutical compositions
GB1458898A (en) * 1974-03-18 1976-12-15 Science Union & Cie Ortho alkoxyanilides a process for their preparation and pharmaceutical compositions containing them
CS195321B2 (en) * 1975-12-23 1980-01-31 Ciba Geigy Ag Plant growth suppressing agents
JPS5334585A (en) * 1976-09-13 1978-03-31 Takashi Sakakibara Spectroscopy system for xxray analysis
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
EP0078765B1 (fr) * 1981-11-02 1986-02-26 Cermol S.A. Dérivés de p-acylaminophénol à effet thérapeutique, procédé pour leur préparation, et composition à effet thérapeutique contenant lesdits dérivés à titre d'ingrédients pharmacologiquement actifs
BRPI0404222A (pt) * 2004-06-07 2006-02-07 Fundacao Oswaldo Cruz Compostos derivados da lidocaìna, composições farmacêuticas contendo os mesmos, uso das respectivas composições farmacêuticas no tratamento, prevenção ou inibição de doenças bem como o método de tratamento, prevenção ou inibição de doenças com as ditas composições farmacêuticas

Also Published As

Publication number Publication date
NL7007517A (en:Method) 1970-12-01
JPS4941184B1 (en:Method) 1974-11-07
NL166473B (nl) 1981-03-16
DE2024693C3 (de) 1979-09-13
NL166473C (nl) 1981-08-17
DE2024693B2 (de) 1979-01-25
CH509975A (fr) 1971-07-15
FR2043489A1 (en:Method) 1971-02-19
BE750619A (fr) 1970-11-03
GB1268587A (en) 1972-03-29
DE2024693A1 (de) 1970-12-03
US3729470A (en) 1973-04-24

Similar Documents

Publication Publication Date Title
AU2270770A (en:Method)
CS153088B2 (en:Method)
AU465413B2 (en:Method)
AU429630B2 (en:Method)
FR2043489A1 (en:Method)
AU427401B2 (en:Method)
AU442380B2 (en:Method)
AU438128B2 (en:Method)
AU442285B2 (en:Method)
AU442535B2 (en:Method)
AU442322B2 (en:Method)
AU428129B2 (en:Method)
AU442357B2 (en:Method)
AU470661B1 (en:Method)
AU410358B2 (en:Method)
AU425297B2 (en:Method)
AU442554B2 (en:Method)
AU428074B2 (en:Method)
AU5598769A (en:Method)
AU5988769A (en:Method)
AU6261969A (en:Method)
CS148398B1 (en:Method)
CS149981B1 (en:Method)
AR203167Q (en:Method)
AU4953367A (en:Method)

Legal Events

Date Code Title Description
TP Transmission of property